Chemoinformaics analysis of 1,2-Dihydrovomilenine
| Molecular Weight | 352.434 | nRot | 1 |
| Heavy Atom Molecular Weight | 328.242 | nRig | 26 |
| Exact Molecular Weight | 352.179 | nRing | 7 |
| Solubility: LogS | -3.546 | nHRing | 5 |
| Solubility: LogP | 1.794 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 5 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 5 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 55.679 |
| nHD | 2 | BPOL | 28.961 |
| QED | 0.598 |
| Synth | 6.662 |
| Natural Product Likeliness | 2.222 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.046 |
| Pgp-sub | 0.924 |
| HIA | 0.962 |
| CACO-2 | -5.212 |
| MDCK | 0.0000111 |
| BBB | 0.026 |
| PPB | 0.831569 |
| VDSS | 1.369 |
| FU | 0.166476 |
| CYP1A2-inh | 0.116 |
| CYP1A2-sub | 0.055 |
| CYP2c19-inh | 0.124 |
| CYP2c19-sub | 0.084 |
| CYP2c9-inh | 0.348 |
| CYP2c9-sub | 0.104 |
| CYP2d6-inh | 0.058 |
| CYP2d6-sub | 0.65 |
| CYP3a4-inh | 0.73 |
| CYP3a4-sub | 0.437 |
| CL | 4.068 |
| T12 | 0.199 |
| hERG | 0.036 |
| Ames | 0.076 |
| ROA | 0.843 |
| SkinSen | 0.265 |
| Carcinogencity | 0.052 |
| EI | 0.01 |
| Respiratory | 0.921 |
| NR-Aromatase | 0.001 |
| Antiviral | No |
| Prediction | 0.671817 |